KREMPA DAVID (Chief Business Officer) sold 8.8% of their position (4.17K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $229.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/6/2026ACC: 0001437749-26-032240
Officer· Chief Business Officer
Since Mar 2023
-4.17K
Net shares
Net seller
$229.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.52K acquired · 14.69K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.52K
Price / share
—
Trade value
—
% of position
28.4%
10/2/2026
37.02K→47.55K
Common Stock
Direct
Shares
−4.17K
Price / share
$55.07
Trade value
$229.41K
% of position
8.8%
10/6/2026
47.55K→43.38K
Total
Net shares
+6.36K
Net value
-$229.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2026 | M · Option Exercise | +10.52K | — | — | 28.4% | 37.02K | 47.55K |
| Common Stock Direct | 10/6/2026 | S · Sale | −4.17K | $55.07 | $229.41K | 8.8% | 47.55K | 43.38K |
| Total | +6.36K | -$229.41K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
10.52K shares
Shares
−10.52K
Strike price
0
Held after
21.04K
Exercisable
—
10/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock10.52K shares | 10/2/2026 | M · Option Exercise | −10.52K | 0 | — | 21.04K |